Cargando…

Biomarkers for Prostate Cancer: From Diagnosis to Treatment

Prostate cancer (PCa) is a widespread malignancy with global significance, which substantially affects cancer-related mortality. Its spectrum varies widely, from slow-progressing cases to aggressive or even lethal forms. Effective patient stratification into risk groups is crucial to therapeutic dec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Jia-Yan, Wang, Pei-Yan, Liu, Ming-Zhu, Lyu, Feng, Ma, Ming-Wei, Ren, Xue-Ying, Gao, Xian-Shu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649216/ https://www.ncbi.nlm.nih.gov/pubmed/37958246 http://dx.doi.org/10.3390/diagnostics13213350

Ejemplares similares

Uncovering the Secrets of Prostate Cancer’s Radiotherapy Resistance: Advances in Mechanism Research
por: Lyu, Feng, et al.
Publicado: (2023)

Population-Based Comparison of Different Risk Stratification Systems Among Prostate Cancer Patients
por: Xie, Mu, et al.
Publicado: (2021)

Development of a nomogram predicting metastatic disease and the assessment of NCCN, AUA and EAU guideline recommendations for bone imaging in prostate cancer patients
por: Ma, Ming-Wei, et al.
Publicado: (2020)

Outcomes of High-Dose Stereotactic Ablative Radiotherapy to All/Multiple Sites for Oligometastatic Renal Cell Cancer Patients
por: Ma, Ming-Wei, et al.
Publicado: (2022)

Circulating miRNAs as Biomarkers for Prostate Cancer Diagnosis in Subjects with Benign Prostatic Hyperplasia
por: Jin, Wei, et al.
Publicado: (2020)

Emerging biomarkers in the diagnosis of prostate cancer
por: Filella, Xavier, et al.
Publicado: (2018)

Modern biomarkers in prostate cancer diagnosis
por: Porzycki, Paweł, et al.
Publicado: (2020)

Biomarkers of Aggressive Prostate Cancer at Diagnosis
por: Boehm, Brock E., et al.
Publicado: (2023)

Susceptibility Weighted Imaging: A New Tool in the Diagnosis of Prostate Cancer and Detection of Prostatic Calcification
por: Bai, Yan, et al.
Publicado: (2013)

Anti-tumor activities of Panax quinquefolius saponins and potential biomarkers in prostate cancer
por: He, Shan, et al.
Publicado: (2021)

Identification of biomarkers, pathways and potential therapeutic target for docetaxel resistant prostate cancer
por: Liu, Rui-ji, et al.
Publicado: (2021)

Identification of Novel Diagnosis Biomarkers for Therapy-Related Neuroendocrine Prostate Cancer
por: Zhang, Cuijian, et al.
Publicado: (2021)

On the Road to Accurate Protein Biomarkers in Prostate Cancer Diagnosis and Prognosis: Current Status and Future Advances
por: Yan, Yiwu, et al.
Publicado: (2021)

Identification alpha-2-HS-glycoprotein precursor and tubulin beta chain as serology diagnosis biomarker of colorectal cancer
por: Fan, Nai-Jun, et al.
Publicado: (2014)

Radiation therapy for nonmetastatic medically inoperable upper-tract urothelial carcinoma
por: Liu, Ming-Zhu, et al.
Publicado: (2021)

GPR160 is a potential biomarker associated with prostate cancer
por: Guo, Wanjing, et al.
Publicado: (2021)

Association between polymorphisms in selected inflammatory response genes and the risk of prostate cancer
por: Chen, Jun, et al.
Publicado: (2016)

tRNA-Derived RNA Fragments Are Novel Biomarkers for Diagnosis, Prognosis, and Tumor Subtypes in Prostate Cancer
por: Liu, Weigang, et al.
Publicado: (2023)

Extracellular vesicles: the next generation of biomarkers for liquid biopsy-based prostate cancer diagnosis
por: Pang, Bairen, et al.
Publicado: (2020)

Current early diagnostic biomarkers of prostate cancer
por: Qu, Min, et al.
Publicado: (2014)

Comparison of biparametric and multiparametric MRI in the diagnosis of prostate cancer
por: Xu, Lili, et al.
Publicado: (2019)

Deep learning based radiomics for gastrointestinal cancer diagnosis and treatment: A minireview
por: Wong, Pak Kin, et al.
Publicado: (2022)

Optimal contouring of seminal vesicle for definitive radiotherapy of localized prostate cancer: comparison between EORTC prostate cancer radiotherapy guideline, RTOG0815 protocol and actual anatomy
por: Qi, Xin, et al.
Publicado: (2014)

The function of oxytocin: a potential biomarker for prostate cancer diagnosis and promoter of prostate cancer
por: Xu, Huan, et al.
Publicado: (2017)

Contrast-enhanced ultrasound targeted versus conventional ultrasound guided systematic prostate biopsy for the accurate diagnosis of prostate cancer: A meta-analysis
por: Zhang, Ming, et al.
Publicado: (2022)

Diagnosis of Prostate Cancer in Patients with Prostate-Specific Antigen (PSA) in the Gray Area: Construction of 2 Predictive Models
por: Chen, Ming, et al.
Publicado: (2021)

Distinguishable Colorimetric Biosensor for Diagnosis of Prostate Cancer Bone Metastases
por: Li, Ming, et al.
Publicado: (2023)

Variability of α/β ratios for prostate cancer with the fractionation schedule: caution against using the linear-quadratic model for hypofractionated radiotherapy
por: Cui, Ming, et al.
Publicado: (2022)

The Application of Radiolabeled Targeted Molecular Probes for the Diagnosis and Treatment of Prostate Cancer
por: Cheng, Luyi, et al.
Publicado: (2023)

Application evaluation of DCE-MRI combined with quantitative analysis of DWI for the diagnosis of prostate cancer
por: Ma, Xiang-Zheng, et al.
Publicado: (2019)

Five candidate biomarkers associated with the diagnosis and prognosis of cervical cancer
por: Han, Hong-Yan, et al.
Publicado: (2021)

Alteration in TET1 as potential biomarker for immune checkpoint blockade in multiple cancers
por: Wu, Hao-Xiang, et al.
Publicado: (2019)

MRl of Prostate Cancer Antigen Expression for Diagnosis and lmmunotherapy
por: Ren, Jing, et al.
Publicado: (2012)

Commentary: Treatment of prostate cancer
por: Lyu, Jiaju, et al.
Publicado: (2021)

Intra-rectal use of epinephrine in radiotherapy of prostate cancer
por: Qin, Shang-Bin, et al.
Publicado: (2019)

MicroRNAs as Biomarkers for Diagnosis, Prognosis and Theranostics in Prostate Cancer
por: Bertoli, Gloria, et al.
Publicado: (2016)

Thiol Groups as a Biomarker for the Diagnosis and Prognosis of Prostate Cancer
por: Koike, Alexsandro, et al.
Publicado: (2020)

Use of MicroRNAs as biomarkers in the early diagnosis of prostate cancer
por: Canatan, Duran, et al.
Publicado: (2022)

Direct comparison of choline PET/CT and MRI in the diagnosis of lymph node metastases in patients with prostate cancer
por: Huang, Shi-ming, et al.
Publicado: (2018)

Systematic Appraisal of Guidelines for the Diagnosis and Treatment of Choledocholithiasis
por: Zhu, Shu-Yao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mp1vmoenfbccef9uc0mpeve28d